We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+19.09%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$3.27B
AUM Growth
-$5.76B
Cap. Flow
-$1.51B
Cap. Flow %
-46.09%
Top 10 Hldgs %
34.23%
Holding
5,681
New
749
Increased
1,274
Reduced
3,081
Closed
446

Sector Composition

Rank Sector Weight
1 Technology 9.66%
2 Financials 8.46%
3 Healthcare 8.24%
4 Consumer Discretionary 7.74%
5 Industrials 6.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
STXS icon
3576
Stereotaxis
STXS
$137M
$30K ﹤0.01%
5,954
-36,626
-86% -$150K
TRC icon
3577
Tejon Ranch
TRC
$443M
$30K ﹤0.01%
2,029
-74,903
-97% -$1.09M
ZTO icon
3578
ZTO Express
ZTO
$17.4B
$30K ﹤0.01%
1,035
-51,233
-98% -$1.5M
ALR
3579
DELISTED
AlerisLife Inc
ALR
$30K ﹤0.01%
4,392
-13,924
-76% -$80.7K
FFBW
3580
DELISTED
FFBW, Inc. Common Stock
FFBW
$30K ﹤0.01%
2,945
-2,787
-49% -$26.8K
NTUS
3581
DELISTED
Natus Medical Inc
NTUS
$30K ﹤0.01%
1,490
-29,981
-95% -$587K
SRRA
3582
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
$30K ﹤0.01%
1,902
+1,521
+399% +$21.1K
WVFC
3583
DELISTED
WVS Financial Corp
WVFC
$30K ﹤0.01%
2,102
+1,044
+99% +$15K
ACBI
3584
DELISTED
Atlantic Capital Bancshares, Inc. Common Stock
ACBI
$30K ﹤0.01%
1,922
-20,307
-91% -$296K
APHA
3585
DELISTED
Aphria Inc. Common Shares
APHA
$30K ﹤0.01%
4,421
+507
+13% +$3.16K
ABEO icon
3586
Abeona Therapeutics
ABEO
$361M
$29K ﹤0.01%
745
-2,031
-73% -$69.2K
FABC
3587
Fabric.AI Inc
FABC
$18.3M
$29K ﹤0.01%
+37
New +$22.5K
CPSS icon
3588
Consumer Portfolio Services
CPSS
$208M
$29K ﹤0.01%
+6,929
New +$27.9K
CRK icon
3589
Comstock Resources
CRK
$3.99B
$29K ﹤0.01%
6,668
-72,964
-92% -$361K
CYTK icon
3590
Cytokinetics
CYTK
$10.2B
$29K ﹤0.01%
1,383
-2,164
-61% -$39.5K
EWW icon
3591
iShares MSCI Mexico ETF
EWW
$1.87B
$29K ﹤0.01%
+663
New +$25.7K
FBIO icon
3592
Fortress Biotech
FBIO
$99M
$29K ﹤0.01%
612
-3,193
-84% -$138K
GBX icon
3593
The Greenbrier Companies
GBX
$1.42B
$29K ﹤0.01%
798
-34,435
-98% -$1.14M
INZY
3594
DELISTED
Inozyme Pharma
INZY
$29K ﹤0.01%
1,400
+141
+11% +$3.36K
LRGF icon
3595
iShares US Equity Factor ETF
LRGF
$3.74B
$29K ﹤0.01%
766
-20,485
-96% -$729K
MCS icon
3596
Marcus Corp
MCS
$929M
$29K ﹤0.01%
2,130
-25,575
-92% -$259K
MGNX icon
3597
MacroGenics
MGNX
$259M
$29K ﹤0.01%
1,269
-955
-43% -$22K
NSSC icon
3598
Napco Security Technologies
NSSC
$1.37B
$29K ﹤0.01%
2,212
-26,628
-92% -$359K
OPOF
3599
DELISTED
Old Point Financial
OPOF
$29K ﹤0.01%
1,491
-1,899
-56% -$32.6K
OPRT icon
3600
Oportun Financial
OPRT
$351M
$29K ﹤0.01%
1,492
-17,386
-92% -$284K

Similar funds

Tower Research Capital (TRC)'s Q4 2020 Portfolio in Review

As of Q4 2020, Tower Research Capital (TRC) held 5,681 positions worth $3.27B, down 64% from $9.03B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Tower Research Capital (TRC) withdrew a net $1.51B in Q4 2020, closing 446 positions and reducing 3,081 holdings. Its most notable exit was iShares Russell 2000 Growth ETF, an estimated $13.7M position sold in full.

By sector, the portfolio is most concentrated in Technology at 9.7% of assets, up from 6.3% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Tower Research Capital (TRC) opened a new position in iShares Russell 1000 ETF worth $24.4M.

  • Tower Research Capital (TRC)'s largest Q4 2020 buy was iShares Russell 1000 ETF: 115,321 shares worth $24.4M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q4 2020, an estimated $99.8M increase.
  • Tower Research Capital (TRC)'s biggest Q4 2020 reduction was iShares Russell 2000 ETF, cutting an estimated $36.3M.
  • Tower Research Capital (TRC) fully exited iShares Russell 2000 Growth ETF in Q4 2020, selling an estimated $13.7M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 34% of its $3.27B portfolio in Q4 2020.
  • Tower Research Capital (TRC) opened 749 new positions and closed 446 in Q4 2020.
  • Tower Research Capital (TRC)'s portfolio value fell 64% quarter-over-quarter to $3.27B.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2020, filed 16 Feb 2021.